These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32557296)

  • 41. Aerosol devices and asthma therapy.
    Berger W
    Curr Drug Deliv; 2009 Jan; 6(1):38-49. PubMed ID: 19418954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
    Ding B; Small M; Scheffel G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L; Geller D
    Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalation therapy of the future--how will it change the way we treat asthma?
    Lötvall J
    J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
    Roche N; Dekhuijzen PN
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Takaku Y; Kurashima K; Ohta C; Ishiguro T; Kagiyama N; Yanagisawa T; Takayanagi N
    Respir Med; 2017 Feb; 123():110-115. PubMed ID: 28137486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
    Wang R; Conner DP; Li BV
    AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patents And Regulatory Exclusivities On Inhalers For Asthma And COPD, 1986-2020.
    Feldman WB; Bloomfield D; Beall RF; Kesselheim AS
    Health Aff (Millwood); 2022 Jun; 41(6):787-796. PubMed ID: 35579925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Cavalli F; Usmani OS; Rogliani P
    Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
    [No Abstract]   [Full Text] [Related]  

  • 51. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology.
    Acerbi D; Brambilla G; Kottakis I
    Pulm Pharmacol Ther; 2007; 20(3):290-303. PubMed ID: 16890465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of distinctions and parallels between the US and EU guidelines for determination of comparative effectiveness and safety of the orally inhaled drug products.
    Singh GJP
    Eur J Pharm Sci; 2024 Oct; 201():106872. PubMed ID: 39117248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults.
    Melani AS; Zanchetta D; Barbato N; Sestini P; Cinti C; Canessa PA; Aiolfi S; Neri M;
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):439-46. PubMed ID: 15562882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. State of the art and new perspectives on dry powder inhalers.
    Terzano C; Colombo P
    Eur Rev Med Pharmacol Sci; 1999; 3(6):247-54. PubMed ID: 11261735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma.
    Pavia D
    Respirology; 1997; 2 Suppl 1():S5-10. PubMed ID: 9400688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dry powder inhalers: an overview.
    Atkins PJ
    Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How to achieve good compliance with inhaled asthma therapy.
    Crompton GK
    Respir Med; 2004 Oct; 98 Suppl B():S35-40. PubMed ID: 15481287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of lung deposition patterns between different asthma inhalers.
    Newman SP
    J Aerosol Med; 1995 Sep; 8 Suppl 3():S21-6; discussion S27. PubMed ID: 10157895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metered dose inhalers: current and future uses.
    Levy ML
    Br J Clin Pract Suppl; 1997 May; 89():16-21. PubMed ID: 9519508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.